[go: up one dir, main page]

AR002354A1 - Composiciones transdermicas que contienen farmacos de bajo peso molecular que son liquidos a las temperaturas ambientales. - Google Patents

Composiciones transdermicas que contienen farmacos de bajo peso molecular que son liquidos a las temperaturas ambientales.

Info

Publication number
AR002354A1
AR002354A1 ARP960102986A AR10298696A AR002354A1 AR 002354 A1 AR002354 A1 AR 002354A1 AR P960102986 A ARP960102986 A AR P960102986A AR 10298696 A AR10298696 A AR 10298696A AR 002354 A1 AR002354 A1 AR 002354A1
Authority
AR
Argentina
Prior art keywords
molecular weight
low molecular
liquid
drugs
composition
Prior art date
Application number
ARP960102986A
Other languages
English (en)
Original Assignee
Noven Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/578,308 external-priority patent/US6316022B1/en
Application filed by Noven Pharma filed Critical Noven Pharma
Publication of AR002354A1 publication Critical patent/AR002354A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Materials Engineering (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe un composición transdérmica que contiene una mezcla de uno o más polímeros, uno o más fármacos, cuando menos uno de los cuales tiene un bajopeso molecular y es líquido en o a aproximadamente las temperaturas ambientales.La composición está sustancialmente exenta de agua y líquidos quetengan un punto de ebullición normal (a) opcionalmente debajo de las temperaturas de procesamiento, y (b) mayor que, o igual a, la temperatura delos fármacos de bajo pesomolec ular. La composición no sufre de la pérdida sustancial del fármaco de más bajo peso molecular durante la producción delsistema transdérmico. También se describe una composición transdérmica que tiene uno o más fármacos, cuando menosuno de los cuales tiene un bajo pesomolecular y es líquido en o a aproximadamente las temperaturas ambientales, y una matriz polimérica que incluye uno o más polímeros de alta resistencia alesfuerzo cortante. Los polímeros de alta resistencia alesfuerzo cortante reducen el efecto plastificante del fármaco de bajo peso molecular, y tienensuficiente viscosidad y esfuerzo cortante para aplicarse a un ser humano.
ARP960102986A 1995-06-07 1996-06-06 Composiciones transdermicas que contienen farmacos de bajo peso molecular que son liquidos a las temperaturas ambientales. AR002354A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47275995A 1995-06-07 1995-06-07
US08/578,308 US6316022B1 (en) 1995-06-07 1995-12-26 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures

Publications (1)

Publication Number Publication Date
AR002354A1 true AR002354A1 (es) 1998-03-11

Family

ID=27043911

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960102986A AR002354A1 (es) 1995-06-07 1996-06-06 Composiciones transdermicas que contienen farmacos de bajo peso molecular que son liquidos a las temperaturas ambientales.

Country Status (10)

Country Link
US (2) US7993671B2 (es)
EP (1) EP0833671A2 (es)
JP (2) JPH11506744A (es)
AR (1) AR002354A1 (es)
AU (1) AU718096C (es)
CA (1) CA2223588C (es)
IL (1) IL122484A0 (es)
NZ (1) NZ309980A (es)
TW (2) TWI244395B (es)
WO (1) WO1996040085A2 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU718096C (en) * 1995-06-07 2001-11-22 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
US7150881B2 (en) 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
NZ525878A (en) * 1998-12-07 2004-12-24 Elan Pharma Int Ltd A method of treating nicotine dependance with mecamylamine
DE60017831T3 (de) 1999-01-14 2009-12-17 Noven Pharmaceuticals, Inc., Miami Dermale zusammensetzungen
US20030170195A1 (en) 2000-01-10 2003-09-11 Noven Pharmaceuticals, Inc. Compositions and methods for drug delivery
US6974588B1 (en) 1999-12-07 2005-12-13 Elan Pharma International Limited Transdermal patch for delivering volatile liquid drugs
US20040086551A1 (en) 2002-10-30 2004-05-06 Miller Kenneth J. Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
DE10338174A1 (de) 2003-08-20 2005-03-24 Lts Lohmann Therapie-Systeme Ag Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
EP1682102A2 (en) * 2003-09-10 2006-07-26 Noven Pharmaceuticals, Inc. Multi-layer transdermal drug delivery device
RU2356580C2 (ru) * 2003-10-28 2009-05-27 Новен Фармасьютикалз, Инк Композиции и способы, обеспечивающие контролируемую потерю лекарственных средств и доставку в системах трансдермальной доставки лекарственных средств
US20060078602A1 (en) * 2004-10-08 2006-04-13 Noven Pharmaceuticals, Inc. Device for transdermal administration of drugs including acrylic polymers
CA2548864C (en) 2005-06-06 2012-12-11 Nitto Denko Corporation Percutaneous absorption-type pharmaceutical preparation
DE602006003813D1 (de) * 2005-06-06 2009-01-08 Fujimoto Co Ltd Pharmazeutische Zusammensetzung zur perkutane Absorption unter Verwendung von einem Metalchlorid, vorzugsweise Natriumchlorid, zur Vorbeugung von Kohäsionsschwäche
JP5058531B2 (ja) 2005-09-09 2012-10-24 日東電工株式会社 ビソプロロール含有貼付製剤
JP5015562B2 (ja) 2005-12-13 2012-08-29 日東電工株式会社 貼付製剤
JP4945228B2 (ja) 2005-12-13 2012-06-06 日東電工株式会社 ビソプロロール含有貼付製剤
CA2678424C (en) 2007-03-08 2014-05-27 Nitto Denko Corporation Percutaneous administration device of bisoprolol
KR101709361B1 (ko) 2009-05-21 2017-02-22 히사미쓰 세이야꾸 가부시키가이샤 경피 흡수 제제
WO2011068722A1 (en) * 2009-12-01 2011-06-09 Noven Pharmaceuticals, Inc. Transdermal testosterone device and delivery
JP5693026B2 (ja) * 2010-03-12 2015-04-01 株式会社フジモト・コーポレーション セレギリン含有貼付製剤
KR20120137373A (ko) * 2010-04-30 2012-12-20 테이코쿠 팔마 유에스에이, 인코포레이티드 프로필아미노인단 경피 조성물
WO2012092165A1 (en) * 2010-12-29 2012-07-05 Noven Pharmaceuticals, Inc. Transdermal drug delivery system comprising levonorgestrel acetate
TWI433904B (zh) * 2011-01-12 2014-04-11 Taiwan Biotech Co Ltd 多奈哌齊經皮貼片
CA2891467A1 (en) 2012-10-15 2014-04-24 Noven Pharmaceuticals, Inc. Compositions and methods for the transdermal delivery of methylphenidate
KR101856515B1 (ko) 2012-11-02 2018-05-10 테이코쿠 팔마 유에스에이, 인코포레이티드 프로피닐아미노인단 경피 조성물
TW201431554A (zh) 2012-12-28 2014-08-16 Noven Pharma 左炔諾孕酮（ｌｅｖｏｎｏｒｇｅｓｔｒｅｌ）及乙烯雌二醇之經皮藥物遞送系統
JP6359032B2 (ja) 2012-12-28 2018-07-18 ノーヴェン ファーマシューティカルズ インコーポレイテッド 経皮薬物送達用のマルチポリマー組成物
WO2014159582A1 (en) 2013-03-14 2014-10-02 Noven Pharmaceuticals, Inc Amphetamine transdermal compositions with acrylic block copolymer
AR095260A1 (es) 2013-03-15 2015-09-30 Noven Pharma Composiciones de anfetaminas transdérmicas estables y métodos de fabricación
AR095259A1 (es) 2013-03-15 2015-09-30 Noven Pharma Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria
JP2015007209A (ja) 2013-05-31 2015-01-15 株式会社リコー コアシェル型粒子、及びその製造方法
EP3253840B1 (en) 2015-02-06 2019-07-31 Noven Pharmaceuticals, INC. Pressure-sensitive adhesives for transdermal drug delivery
US10406116B2 (en) 2015-02-06 2019-09-10 Noven Pharmaceuticals, Inc. Pressure-sensitive adhesives for transdermal drug delivery
WO2022150431A2 (en) 2021-01-07 2022-07-14 Noven Pharmaceuticals, Inc. Amphetamine carbamate compounds and methods
CA3203041A1 (en) 2021-01-07 2022-07-14 Atsushi Sonobe Transdermal amphetamine compositions with low levels of carbamate

Family Cites Families (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US34579A (en) * 1862-03-04 Island
JPS597689B2 (ja) 1979-12-19 1984-02-20 日東電工株式会社 医薬製剤
JPS56108707A (en) 1980-01-31 1981-08-28 Nitto Electric Ind Co Ltd Production of medical material
JPS57116011A (en) 1981-01-08 1982-07-19 Nitto Electric Ind Co Ltd Pharmaceutical preparation
JPS59205467A (ja) * 1983-05-09 1984-11-21 Nippon Light Metal Co Ltd アルミニウム材の表面に亜鉛拡散処理に適した亜鉛析出層を形成する方法
HU193662B (en) 1983-12-20 1987-11-30 Chinoin Gyogyszer Es Vegyeszet Process for producing synergetic pharmaceutical composition of antidepressive aktivity
JPS61261819A (ja) 1985-05-15 1986-11-19 Konishiroku Photo Ind Co Ltd 磁気記録媒体の製造方法
US5189064A (en) 1985-07-22 1993-02-23 Matrix Technologies, Inc. Treatment of cocaine addiction
JPS6346163A (ja) * 1986-04-15 1988-02-27 株式会社資生堂 外用部材
DE252290T1 (de) 1986-06-10 1988-06-09 Chiesi Farmaceutici S.P.A., Parma Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
ES2028074T3 (es) * 1986-06-13 1992-07-01 Alza Corporation Activacion por humedad de un sistema de suministro transdermico de farmacos.
US5220068A (en) 1986-09-25 1993-06-15 Chinoin Gyogyszer - Es Vegyeszeti Termekek Gyara Rt. Psychostimulant agent
HU207280B (en) 1986-09-25 1993-03-29 Chinoin Gyogyszer Es Vegyeszet Process for producing new phenyl-alkyl-amines and pharmaceutical compositions containing them
US4906169A (en) 1986-12-29 1990-03-06 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
US4868218A (en) 1987-08-18 1989-09-19 Buyske Donald A Method of treating depression
US4861800A (en) 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
JPS6468316A (en) 1987-09-08 1989-03-14 Teikoku Seiyaku Kk External plaster containing salbutamol
KR900000534B1 (ko) 1987-09-25 1990-01-31 한국과학기술원 Cd₁_xZnxS 소결막의 제조방법
JPH082369B2 (ja) 1987-10-13 1996-01-17 株式会社資生堂 外用部材
US5071645A (en) 1987-10-19 1991-12-10 Ppg Industries, Inc. Process of producing an active agent delivery device
US5223540A (en) 1987-10-22 1993-06-29 Massachusetts Institute Of Technology Method for treating the premenstrual or late luteal phase syndrome
US4885154A (en) 1988-03-01 1989-12-05 Alza Corporation Method for reducing sensitization or irritation in transdermal drug delivery and means therefor
US5234957A (en) 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5300291A (en) 1988-03-04 1994-04-05 Noven Pharmaceuticals, Inc. Method and device for the release of drugs to the skin
US4814168A (en) 1988-03-04 1989-03-21 Noven Pharmaceuticals, Inc. Transdermal multipolymer drug delivery system
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US4994267A (en) 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
GB8807504D0 (en) 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
HU208484B (en) 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
US5179126A (en) 1988-10-26 1993-01-12 Massachusettes Institute Of Technology Compositions for treating tobacco withdrawl symtoms and methods for their use
US4999382A (en) 1988-10-26 1991-03-12 Massachusetts Institute Of Technology Compositions for treating tobacco withdrawal symptoms and methods for their use
US5192560A (en) 1989-03-07 1993-03-09 Canon Kabushiki Kaisha Variable mold apparatus
JP2693212B2 (ja) 1989-03-28 1997-12-24 日東電工株式会社 疾患治療用テープ製剤
DE3910543A1 (de) * 1989-04-01 1990-10-11 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung
US4886164A (en) 1989-06-16 1989-12-12 Enviro Med, Inc. Containers for medical waste
JP2512805B2 (ja) 1989-07-14 1996-07-03 積水化学工業株式会社 ケトチフェン経皮吸収製剤
GB2234233B (en) 1989-07-28 1993-02-17 Csir Lithium manganese oxide
US4972037A (en) 1989-08-07 1990-11-20 Minnesota Mining And Manufacturing Company Polysiloxane-grafted copolymer topical binder composition with novel fluorochemical comonomer and method of coating therewith
US5091186A (en) 1989-08-15 1992-02-25 Cygnus Therapeutic Systems Biphasic transdermal drug delivery device
JP2512565B2 (ja) 1989-10-13 1996-07-03 積水化学工業株式会社 貼付剤
US5023591A (en) 1989-11-15 1991-06-11 Allen V. Edwards Anti-theft control apparatus
US5320597A (en) 1991-02-08 1994-06-14 Becton, Dickinson And Company Device and method for renewing electrodes during iontophoresis
US5189084A (en) 1989-12-21 1993-02-23 Ciba-Geigy Corporation Process for incorporating o-hydroxyphenyl-s-triazines in organic polymers
FR2656321B1 (fr) 1989-12-27 1992-03-27 Norsolor Sa Compositions comprenant des copolymeres d'ethylene.
US5190763A (en) 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5192550A (en) 1990-05-07 1993-03-09 Alza Corporation Dosage form for treating central nervous system disorders
US5221536A (en) 1990-05-07 1993-06-22 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
JPH0441033A (ja) 1990-06-04 1992-02-12 Masaji Terada 合鍵複製機
US5057321A (en) 1990-06-13 1991-10-15 Alza Corporation Dosage form comprising drug and maltodextrin
US5128145A (en) 1990-06-13 1992-07-07 Alza Corporation Dosage form for Parkinson's disease, spasticity and muscle spasms
US5135395A (en) 1990-07-05 1992-08-04 Marlin Gerald M Implant collar and post system
US5225446A (en) 1990-08-31 1993-07-06 Deprenyl Animal Health, Inc. Use of 1-deprenyl for retention of specific physiological functions
US5151449A (en) 1990-08-31 1992-09-29 Deprenyl Animal Health, Inc. Use of L-deprenyl for retention of specific physiological functions
US5192808A (en) 1990-08-31 1993-03-09 Deprenyl Animal Health, Inc. Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease)
CA2039194C (en) 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same
US5320850A (en) 1990-10-29 1994-06-14 Alza Corporation Transdermal delivery of the gestogen ST-1435 and devices therefor
US5158537A (en) 1990-10-29 1992-10-27 Alza Corporation Iontophoretic delivery device and method of hydrating same
JP3016644B2 (ja) 1990-11-30 2000-03-06 三井化学株式会社 ｎ−ブテンの二量化方法
HU209605B (en) 1991-04-15 1994-09-28 Chinoin Gyogyszer Es Vegyeszet Process for production of wather-free transdermal preparation
US5204116A (en) 1991-05-01 1993-04-20 Alza Corporation Dosage form providing immediate therapy followed by prolonged therapy
WO1992021333A2 (en) 1991-05-24 1992-12-10 Pharmavene, Inc. Treatment of drug withdrawal symptoms and drug craving with type b monoamine oxidase inhibitors
US5232702A (en) * 1991-07-22 1993-08-03 Dow Corning Corporation Silicone pressure sensitive adhesive compositons for transdermal drug delivery devices and related medical devices
US5225198A (en) 1991-08-27 1993-07-06 Cygnus Therapeutic Systems Transdermal administration of short or intermediate half-life benzodiazepines
US5254349A (en) 1991-12-06 1993-10-19 Alza Corporation Process for lessening irritation caused by drug
US5200195A (en) 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
US5266332A (en) 1991-12-06 1993-11-30 Alza Corporation Method for administering anti-Parkinson drug
EP0593807A1 (en) * 1992-10-22 1994-04-27 LTS Lohmann Therapie-Systeme GmbH & Co. KG Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
US5242950A (en) 1992-04-23 1993-09-07 Somerset Pharmaceuticals, Inc. Treatment of macular degeneration
DE4224325C1 (de) * 1992-07-23 1994-02-10 Sanol Arznei Schwarz Gmbh Wirkstoffpflaster für niedrigschmelzende und/oder flüchtige Wirkstoffe und Verfahren zu seiner Herstellung
CA2101040C (en) 1992-07-30 1998-08-04 Minori Takagi Video tape recorder with a monitor-equipped built-in camera
GB2271515B (en) 1992-10-14 1995-11-29 Harry Frederick Druce Playing cards for an educational game
US5268332A (en) 1992-11-12 1993-12-07 At&T Bell Laboratories Method of integrated circuit fabrication having planarized dielectrics
ES2164286T3 (es) * 1993-04-20 2002-02-16 Hexal Ag Emplasto con sustancias activas.
CA2166869A1 (en) * 1993-07-09 1995-01-19 Ooi Wong Method and device for providing nicotine replacement therapy transdermally/transbuccally
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
JP3127727B2 (ja) 1994-08-29 2001-01-29 村田機械株式会社 インクリボン用カセット
US6316022B1 (en) * 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
AU718096C (en) 1995-06-07 2001-11-22 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
FR2756563B1 (fr) 1996-12-04 1998-12-24 Synthelabo Derives de benzoate de 1,4-diazabicyclo[2.2.2]oct-2-yl- methyle, leur preparation et leur application en therapeutique
US6007406A (en) 1997-12-04 1999-12-28 Micron Technology, Inc. Polishing systems, methods of polishing substrates, and method of preparing liquids for semiconductor fabrication process
US6221538B1 (en) 1998-03-02 2001-04-24 Motorola, Inc. Method for automating manufacture of photomask
US6128146A (en) 1998-07-07 2000-10-03 Lucent Technologies Inc. Undershoot active damping circuit for write drivers
GB2340951B (en) 1998-08-20 2000-07-12 Gec Avery Ltd Weight simulation calibration rig and method
JP3939458B2 (ja) 1999-03-23 2007-07-04 株式会社クラレ 背面投写型スクリーン
EP2022522B1 (de) 2007-07-25 2011-12-28 W & H Dentalwerk Bürmoos GmbH Vorrichtung und Verfahren zur Injektion von Medien in menschliche und tierische Gewebe

Also Published As

Publication number Publication date
US8337884B2 (en) 2012-12-25
WO1996040085A3 (en) 1997-03-13
EP0833671A2 (en) 1998-04-08
JP2005023088A (ja) 2005-01-27
AU718096B2 (en) 2000-04-06
TW492880B (en) 2002-07-01
CA2223588A1 (en) 1996-12-19
JP5068003B2 (ja) 2012-11-07
IL122484A0 (en) 1998-06-15
US20110165222A1 (en) 2011-07-07
AU6028996A (en) 1996-12-30
CA2223588C (en) 2004-01-06
TWI244395B (en) 2005-12-01
WO1996040085A2 (en) 1996-12-19
AU718096C (en) 2001-11-22
JPH11506744A (ja) 1999-06-15
US20020058058A1 (en) 2002-05-16
US7993671B2 (en) 2011-08-09
NZ309980A (en) 2001-06-29

Similar Documents

Publication Publication Date Title
AR002354A1 (es) Composiciones transdermicas que contienen farmacos de bajo peso molecular que son liquidos a las temperaturas ambientales.
ATE257407T1 (de) Herstellung von peptidhältigen, biologisch abbaubaren mikrokügelchen durch ein schmelzverfahren
BR9104494A (pt) Processo para a separacao de acidos organicos fracos de baixo peso molecular,de uma mistura liquida que os contem,e resina de troca anionica de base fraca e tipo gel
DK0644771T3 (da) Lægemiddelsystem til levering af erythropoietin
ES2052557T3 (es) Composiciones y metodos de impermeabilizar tierras.
ES2143122T3 (es) Sulfonimidamidas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
DK0467389T3 (da) Lægemiddelafgivelsessystem, der involverer interaktion mellem protein eller polypeptid og hydrofob bionedbrydelig polymer
IT1035485B (it) Procedimento per la produzione di dispersioni polimeriche stabili e di bassa viscosita pro dotto ottenuto e poliuretani da esso ottenutti
MX174079B (es) Procedimiento para la preparacion continua de soluciones homogeneas de polimeros de peso molecular alto
KR910009240A (ko) 약제학적 또는 치료학적 활성제의 수송 시스템
PT84188B (pt) Processo de preparacao de uma composicao farmaceutica para a obtencao de um hidrogel ou de uma suspensao, muito viscosos
ES2143525T3 (es) Dispositivo medico elastomerico.
ES2072871T3 (es) Coadyuvante de proceso para una resina termoplastica, y composicion de resina termoplastica que lo contiene.
ES2062073T3 (es) Composiciones de tinta que contiene una mezcla de un poliester, un polimero acrilico y un polimero vinilico.
ES2058081T3 (es) Poliesteres que contienen bloques de oxido de alquileno como sistemas de administracion de medicamentos.
ES2128704T3 (es) Polilactidas procesables.
DE3780218D1 (de) Tumor-nekrose-faktor-formulierung und ihre herstellung.
DE69710879D1 (de) Arzneimittel auf basis von progesteron und östradiol
AR003928A1 (es) Comprimido del liberacion controlada
ES2057339T3 (es) Medicamento para la aplicacion por via subcutanea o intramuscular que contiene polipeptidos.
AR007649A1 (es) Composicion de relleno para forma de dosis farmaceutica de gelatina blanda y forma de dosis farmaceutica que la comprende
ES2136123T3 (es) Derivado de silicona modificado por el fluor; produccion de este derivado y cosmetico que los contiene.
AR007860A1 (es) Procedimiento para elaborar elastomeros al menos parcialmente reticulados, los elastomeros que se obtienen con dicho procedimiento; composicionestermoplasticas procesables en fusion que incluyen dichos elastomeros y articulos fabricados con dichos elastomeros.
KR920009419A (ko) 키토산을 함유하는 혼화성 블렌드
ES2139795T3 (es) Procedimiento para la preparacion de copoliesteres lineales que contienen acido omega-hidroxicarboxilico.

Legal Events

Date Code Title Description
FC Refusal